Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 40 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 40 samples: 35 distinct titles, 3 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive RhabdomyosarcomaOncogene · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE279337_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1171882 and SRA study SRP538024. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 40 sample titles: 35 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8567468 Rh30,vehicle,DMSO,control,replicate1
- GSM8567469 Rh30,vehicle,DMSO,control,replicate2
- GSM8567470 Rh30,vehicle,DMSO,control,replicate3
- GSM8567471 Rh30,drug,1uMYK-4-279,replicate1
- GSM8567472 Rh30,drug,1uMYK-4-279,replicate2
- GSM8567473 Rh30,drug,1uMYK-4-279,replicate3
- GSM8567474 Rh30,P3F
- GSM8567475 Rh30,Scramble,P3F
- GSM8567476 Rh30,shKDM3A,P3F
- GSM8567477 Rh30,shETS1,P3F
- GSM8567478 Rh30,KDM3A
- GSM8567479 Rh30,Scramble,KDM3A
- GSM8567480 Rh30,shKDM3A,KDM3A
- GSM8567481 Rh30,shETS1,KDM3A
- GSM8567482 Rh30,ETS1
- GSM8567483 Rh30,Scramble,ETS1
- GSM8567484 Rh30,shKDM3A,ETS1
- GSM8567485 Rh30,shETS1,ETS1
- GSM8567486 Rh30,DMSO,P3F
- GSM8567487 Rh30,YK,P3F
- GSM8567488 Rh30,BRG1
- GSM8567489 Rh30,Scramble,BRG1
- GSM8567490 Rh41,ETS1
- GSM8567491 Rh41,Scramble,ETS1
- GSM8567492 Rh41,shETS1,ETS1
- GSM8567493 Rh41,KDM3A
- GSM8567494 Rh41,Scramble,KDM3A
- GSM8567495 Rh41,shETS1,KDM3A
- GSM8567496 Rh41,shKDM3A,KDM3A
- GSM8567497 Rh41,P3F
- GSM8567498 Rh41,Scramble,P3F,rep1
- GSM8567499 Rh41,shETS1,P3F
- GSM8567500 Rh41,Scramble,P3F,rep2
- GSM8567501 Rh41,shKDM3A,P3F
- GSM8567502 Rh41,DMSO,P3F
- GSM8567503 Rh41,YK,P3F
- GSM8567504 Rh41,DMSO,ETS1
- GSM8567505 Rh41,YK,ETS1
- GSM8567506 Rh41,BRG1
- GSM8567507 Rh41,Scramble,BRG1
- GSE286950 PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 16 samples same disease briefing · shares pax3-foxo1, rhabdomyosarcoma, targetable
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares rhabdomyosarcoma, fusion-positive
- GSE325716 The MEK/MYC/p21 Axis Drives Senescence Bypass and BCL-xL Dependence in Vincristine-Resistant Rhabdomyosarcoma 4 samples same disease briefing · shares rhabdomyosarcoma, dependence
- GSE274640 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma. 80 samples same disease briefing · shares rhabdomyosarcoma
- GSE276201 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma 28 samples same disease briefing · shares rhabdomyosarcoma
- GSE312030 Combined inhibition of HRAS and MEK induces tumor regression and restores myogenic differentiation in HRAS-mutant rhabdomyosarcoma 159 samples same disease briefing · shares rhabdomyosarcoma
- GSE303028 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma 104 samples same disease briefing · shares rhabdomyosarcoma
- GSE253895 PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma 58 samples same disease briefing · shares rhabdomyosarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.